PATENT CLAIM ANALYSIS

Application Number: 16015227
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "395000"]

Abstract:
The present invention belongs to the pharmaceutical field, and relates to a preparation method for a series of benzimidazole derivatives, their pharmaceutical salts and pharmaceutically acceptable prodrugs, a pharmaceutical composition containing the derivatives, and the uses of the derivatives and pharmaceutical composition in the preparation of antigout drugs and in the treatment of related diseases.

Claim (Index 12):
The method of  claim 11 , wherein said second drug is selected from the group consisting of URAT1 inhibitor, xanthine oxidase inhibitor, xanthine dehydrogenase, xanthine oxidoreductase inhibitor, purine nucleoside phosphorylase inhibitor, uric acid transporter inhibitor, glucose transporter inhibitor, organic anion transporter (OAT) inhibitor, OAT-4 inhibitor and any combinations thereof.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 94.0
- Lexical Diversity: 1.76471
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14777317', '15492306', '14576683', '14210888', '14911000']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8244155570635975
- 35 USC 102 Novelty (BERT): 0.5281984608315021
- Combined Prediction Score: 0.794793847440388
- Mean Citation Score: 317.392386
- Max Citation Score: 349.67477
- Similarity Product: 226.2971267847657

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test